Common cough medicine revealed to slow down Parkinson's disease and dementia - A 12-month study found that Ambroxol helped ...

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

Despite a significant improvement in symptoms, around 20% of patients discontinued treatment due to adverse events.

A drug used for Parkinson's disease has been shown to be effective in reducing the symptoms of difficult to treat depression, ...

Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work ...

After presentations to the International Linked Clinical Trials (iLCT), which was set up by Cure Parkinson’s over a decade ...

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...

The new study surveyed 634 people with Parkinson’s disease, or PD. It finds that people with PD report that tremor is one of ...

Parkinson’s disease is primarily distinguished by resting tremors, bradykinesia, muscle rigidity, and balance issues, all of which have a substantial influence on patients' quality of life. Although ...

Understand Parkinson's disease, its symptoms, and the crucial role of clinical trials in treatment and research, especially for Black Americans.

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...